Venous thromboembolism during pregnancy or postpartum: Findings from the RIETE Registry
Authors:
- Manuel MonrealMMManuel Monreal
- for the RIETE InvestigatorsFIfor the RIETE Investigators
- 1 January 2007
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 97 (02) , 186-190
Abstract
Summary: Venous thromboembolism (VTE) occurs infrequently during pregnancy, and issues concerning its natural history, prevention and therapy remain unresolved. RIETE is an ongoing registry of consecutive patients with objectively confirmed, symptomatic acute VTE. In this analysis, we compared the clinical characteristics and outcome for all enrolled pregnant and postpartum women with acuteVTE, and all non-pregnant women in the same age range. Up to May 2005, 11,630 patients were enrolled in RIETE, of whom 848 (7.3%) were women aged < 47 years. Of them, 72 (8.5%) were pregnant, 64 (7.5%) postpartum. Pregnant women presented less often with symptomatic pulmonary embolism (11%) than non-pregnant women (39%). VTE developed during the first trimester in 29 (40%) pregnant patients; in the second in 13; in the third in 30. Thrombophilia tests were m Venous thromboembolism (VTE) occurs infrequently during pregnancy, and issues concerning its natural history, prevention and therapy remain unresolved. RIETE is an ongoing registry of consecutive patients with objectively confirmed, symptomatic acute VTE. In this analysis, we compared the clinical characteristics and outcome for all enrolled pregnant and postpartum women with acuteVTE, and all non-pregnant women in the same age range. Up to May 2005, 11,630 patients were enrolled in RIETE, of whom 848 (7.3%) were women aged < 47 years. Of them, 72 (8.5%) were pregnant, 64 (7.5%) postpartum. Pregnant women presented less often with symptomatic pulmonary embolism (11%) than non-pregnant women (39%). VTE developed during the first trimester in 29 (40%) pregnant patients; in the second in 13; in the third in 30. Thrombophilia tests were mKeywords
Funding Information
- Red Respira from the Instituto Carlos III ((RedRespira-ISCiii-RTIC-03/11))
This publication has 9 references indexed in Scilit:
- Associations between fetal inherited thrombophilia and adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2006
- A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulationAmerican Journal of Obstetrics and Gynecology, 2004
- Tinzaparin sodium for thrombosis treatment and prevention during pregnancyAmerican Journal of Obstetrics and Gynecology, 2004
- Maternal thrombophilias are not associated with early pregnancy lossThrombosis and Haemostasis, 2004
- Prophylactic and therapeutic enoxaparin during pregnancy: Indications, outcomes and monitoringAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2003
- Absence of Association of Thrombophilia Polymorphisms with Intrauterine Growth RestrictionNew England Journal of Medicine, 2002
- Mutations in Coagulation Factors in Women with Unexplained Late Fetal LossNew England Journal of Medicine, 2000
- Deep Vein Thrombosis During Pregnancy and the Puerperium: A Meta-Analysis of the Period of Risk and the Leg of PresentationObstetrical & Gynecological Survey, 1999
- Increased Frequency of Genetic Thrombophilia in Women with Complications of PregnancyNew England Journal of Medicine, 1999